ConexiantADHD Stimulant Misuse Under Review

🧠 Mental Health / Behavioral Sensitivity

A rapid review commissioned by the FDA evaluated US evidence on ADHD stimulant misuse from 64 studies published between 2004 and 2024. Researchers examined prevalence, motivations, acquisition sources, routes of administration, and health consequences.

Clinical Considerations

• National surveys suggest declining Adderall misuse among young adults, though millions still report annual stimulant misuse.
• High-frequency misuse was associated with greater polysubstance use and different acquisition pathways than infrequent misuse.
• Intentional stimulant exposures were linked to higher rates of critical-care utilization and psychiatric admissions.
• No reviewed longitudinal studies evaluated long-term cardiovascular, neurologic, or other physical health consequences.

Practice Applications

• Recognize stimulant misuse remains clinically relevant despite declining prevalence.
• Monitor concurrent substance use among patients reporting stimulant misuse.
• Interpret prevalence trends cautiously because survey methodologies changed over time.
• Avoid assuming long-term health risks are fully characterized by available evidence.